April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Variable Ocular Phenotype and Confirmation of Tfap2a Gene Involvement in Branchio-Oculo-Facial Syndrome (BOFS)
Author Affiliations & Notes
  • H. Dollfus
    Laboratoire EA 3941, Faculte de Medecine, Universite Louis Pasteur-Avenir Inserm, Strasbourg, France
  • V. Pelletier
    Centre de référence maladies rares CARGO, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  • J.-M. Danse
    Laboratoire EA 3941, Faculte de Medecine, Universite Louis Pasteur-Avenir Inserm, Strasbourg, France
  • B. Leheup
    Department of genetics, CHU Nancy, Nancy, France
  • J. Vigneron
    Genetics, Maternité Pinard, Nancy, France
  • S. Hellé
    Laboratoire EA 3941, Faculte de Medecine, Universite Louis Pasteur-Avenir Inserm, Strasbourg, France
  • C. Stoetzel
    Laboratoire EA 3941, Faculte de Medecine, Universite Louis Pasteur-Avenir Inserm, Strasbourg, France
  • Footnotes
    Commercial Relationships  H. Dollfus, None; V. Pelletier, None; J.-M. Danse, None; B. Leheup, None; J. Vigneron, None; S. Hellé, None; C. Stoetzel, None.
  • Footnotes
    Support  Avenir Inserm Programm
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4099. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Dollfus, V. Pelletier, J.-M. Danse, B. Leheup, J. Vigneron, S. Hellé, C. Stoetzel; Variable Ocular Phenotype and Confirmation of Tfap2a Gene Involvement in Branchio-Oculo-Facial Syndrome (BOFS). Invest. Ophthalmol. Vis. Sci. 2009;50(13):4099.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Branchio-Oculo-Facial Syndrome (BOFS) is an autosomal dominant condition characterized by three main features respectively: branchial defects, ocular anomalies that may lead to blindness and craniofacial anomalies including cleft lip/palate.

Methods: : We report on one familial case with three affected, and two sporadic cases that did not show cryptic chromosomal aberrations on microarray analysis and were subsequently screened for mutations in the recently identified TFAP2A gene.

Results: : Three point mutations (S239P,L249P, L218P), of which two are novel, were identified confirming the TFAP2A gene as the causative gene in BOFS.

Conclusions: : This report confirms the involvement of this transcription factor TFAP2A in this developmental syndrome that discloses important clinical variability especially at the level of the eye including: congenital nasolacrimal duct defect, cystic or non cystic microphthalmia and coloboma of various degree.

Keywords: genetics • mutations • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×